Document Detail

Autonomous bacterial localization and gene expression based on nearby cell receptor density.
Jump to Full Text
MedLine Citation:
PMID:  23340842     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Escherichia coli were genetically modified to enable programmed motility, sensing, and actuation based on the density of features on nearby surfaces. Then, based on calculated feature density, these cells expressed marker proteins to indicate phenotypic response. Specifically, site-specific synthesis of bacterial quorum sensing autoinducer-2 (AI-2) is used to initiate and recruit motile cells. In our model system, we rewired E. coli's AI-2 signaling pathway to direct bacteria to a squamous cancer cell line of head and neck (SCCHN), where they initiate synthesis of a reporter (drug surrogate) based on a threshold density of epidermal growth factor receptor (EGFR). This represents a new type of controller for targeted drug delivery as actuation (synthesis and delivery) depends on a receptor density marking the diseased cell. The ability to survey local surfaces and initiate gene expression based on feature density represents a new area-based switch in synthetic biology that will find use beyond the proposed cancer model here.
Authors:
Hsuan-Chen Wu; Chen-Yu Tsao; David N Quan; Yi Cheng; Matthew D Servinsky; Karen K Carter; Kathleen J Jee; Jessica L Terrell; Amin Zargar; Gary W Rubloff; Gregory F Payne; James J Valdes; William E Bentley
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Molecular systems biology     Volume:  9     ISSN:  1744-4292     ISO Abbreviation:  Mol. Syst. Biol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101235389     Medline TA:  Mol Syst Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  636     Citation Subset:  IM    
Affiliation:
1] Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA [2] Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, MD, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Mol Syst Biol
Journal ID (iso-abbrev): Mol. Syst. Biol
ISSN: 1744-4292
Publisher: Nature Publishing Group
Article Information
Download PDF
Copyright © 2013, EMBO and Macmillan Publishers Limited
open-access:
Received Day: 16 Month: 07 Year: 2012
Accepted Day: 08 Month: 12 Year: 2012
collection publication date: Year: 2013
Electronic publication date: Day: 22 Month: 01 Year: 2013
pmc-release publication date: Day: 22 Month: 01 Year: 2013
Volume: 9First Page: 636 Last Page: 636
PubMed Id: 23340842
ID: 3564257
Publisher Item Identifier: msb201271
DOI: 10.1038/msb.2012.71

Autonomous bacterial localization and gene expression based on nearby cell receptor density
Hsuan-Chen Wu12
Chen-Yu Tsao12
David N Quan12
Yi Cheng3
Matthew D Servinsky4
Karen K Carter25
Kathleen J Jee1
Jessica L Terrell12
Amin Zargar25
Gary W Rubloff3
Gregory F Payne12
James J Valdes6
William E Bentleya125
1Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA
2Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, MD, USA
3Department of Material Science and Engineering, University of Maryland, College Park, MD, USA
4Sensors and Electron Devices Directorate, US Army Research Laboratory, Adelphi, MD, USA
5Department of Chemical and Biomolecular Engineering, University of Maryland, College Park, MD, USA
6US Army Edgewood Chemical Biological Center, Aberdeen Proving Ground, MD, USA
aInstitute for Bioscience and Biotechnology Research, University of Maryland, 5115 Plant Sciences Building, College Park, MD 20742, USA. Tel.:+1 301 405 4321; Fax:+1 301 405 9953; bentley@umd.edu

Introduction

Synthetic biology engenders design-based rewiring of a cell's genetic circuitry for the synthesis of novel products (Kwok, 2010). In such cases, cell populations are aligned for optimal production. While Nature's biosynthetic toolbox is vast—missing are measures that exploit high level functions of cells to enable autonomously computed and directed outcomes (Tsao et al, 2010). That is, a less commonly examined but equally innovative strategy envisions a reprogrammed cell itself or small collections of cells as the end products of synthetic biology, as these cells execute extraordinary tasks (Forbes, 2010). Recently, Saeidi et al (2011) engineered an E. coli to sense and kill nearby pathogenic P. aeruginosa by secreting pyocin S5 in response to its identifying signal molecule, 3OC12HSL. Indeed, engineered signaling or communication networks are envisioned to endow bacteria with the ability to seek out new populations (Defoirdt, 2011). Bacteria have also been engineered to carry and deploy ‘cargo' at selected surfaces (Fernandes et al, 2011). These concepts have yet to be combined for autonomous operation.

Bacteria harness the signal transduction processes of quorum sensing (QS) as a means of inter- and intra-species communication and the coordination of population-based phenotypes. This cell-to-cell communications network is controlled by the synthesis, transport, and sensing of its autoinducer signaling molecules. Contrary to the idea that it is the cell number that initiates a QS response, several studies have demonstrated that autoinducer concentration is the determining factor. That is, by manipulating the autoinducer concentration via genetic, physical, or biochemical means, one can elicit a QS response in even one (Carnes et al, 2010) or a few bacterial cells (Fernandes et al, 2010). For example, we created an autoinducer-2 (AI-2) synthesizing fusion protein (referred to as a ‘nanofactory') onto which any antigen-targeting antibody can be assembled for antigen-localized AI-2 synthesis (Fernandes et al, 2010). This was used to elicit a QS response among one strain from within a mixed culture of two AI-2 responding strains and in the absence of a quorum.

By altering their QS genetic circuits, we engineered bacteria to find cells of interest (diseased or otherwise), dock on associated surface receptors or biomarkers (‘features'), integrate surface feature density, and also decide whether or not to initiate gene expression. This ‘smart' bacterium reinforces the notion of an expanded synthetic biology umbrella that confers new capabilities on the individual cell. The resultant cell has capabilities that could be viewed as analogous to a dirigible—a transport vehicle that autonomously navigates and carries or deploys important cargo.

The particular circumstances of our exploratory experiments leveraged the AI-2 signaling pathway of bacterial QS to direct bacterial swimming to a squamous cancer cell line of the head and neck (SCCHN) and subsequently initiate the synthesis of a reporter protein based on a threshold density of epidermal growth factor receptor (EGFR). Several studies have demonstrated the use of bacteria for both the synthesis and delivery of proteins or other toxins in cancer models (Forbes, 2010). None, however, have demonstrated high level discrimination of tumor from healthy cells with regard to differential surface biomarker profiles. In our case, cell localization was also governed by bacterial chemotaxis, since AI-2 is a chemoattractant, recruiting bacteria to its place of synthesis. Bacterial swimming was thus initiated and guided by site-directed synthesis and diffusion of AI-2 from a template-assembled nanofactory. AI-2 is a chemoattractant and serves as a molecular sentinel that recruits bacteria to its place of synthesis. Upon arrival, the bacteria sensed the prevailing AI-2 concentration that was directly proportional to the local EGFR surface density. A pre-programmed QS response then served to coordinate phenotype by initiating DsRed gene expression within the localized population of bacteria. Overall, this serves as a phenotype ‘focusing' system (Balazsi et al, 2011; Xie et al, 2011) and maintains the switch in an ‘off' state until the desired threshold is reached (Figure 1).


Results
AI-2 synthesis from template-assembled nanofactories and activation of docked bacteria

In Figure 1, the bacterium's motility and switching capabilities rely upon bacterial QS, a density-dependent cell–cell communication process mediated by the transmission and propagation of chemical autoinducers (Miller and Bassler, 2001; Waters and Bassler, 2005). Responding to a threshold autoinducer level coincident with a quorum, cells initiate coordinated changes in gene expression (Hooshangi and Bentley, 2008). Recognizing the complexities of this system that arise from its chemical reaction, diffusion, cell motility, and gene expression components, we first constructed a series of studies using biofabricated surfaces that enabled spatiotemporally controlled microenvironments for elucidating design and fabrication parameters. Receptor and signaling gradients were assembled via avidin-loaded biotin-coated ELISA wells. In Figure 2A, avidin is a target for FITC-labeled rabbit anti-avidin IgG conjugated AI-2 synthesizing nanofactories (NFs) (Fernandes et al, 2010). The NF is a chimeric fusion protein expressed and purified from E. coli consisting of an IgG-binding motif (protein G), two AI-2 synthases, Pfs and LuxS, which convert S-adenosylhomocysteine (SAH) into AI-2, and affinity tags for covalent or metal-ion coupling to surfaces. In Figure 2B, we depict the level of NF binding and AI-2 production as a function of coated avidin. We used a mathematical model for E. coli's AI-2 regulated QS genetic switch (Hooshangi and Bentley, 2011) to evaluate sensitivity and strength of the switch as a function of ambient AI-2 concentration. Correspondingly, we engineered E. coli (W3110 ΔlsrFG ΔluxS) for hypersensitivity to AI-2 and inoculated them into wells above the NF. Upon detection of ∼1–5 μM AI-2, these cells express T7 polymerase that amplifies the native lsr operon response by overexpressing DsRed (see Supplementary Figure 1). NF fluorescence, AI-2 level, and DsRed production from these AI-2 responding cells were all correlated, as expected. NF was bound to the surface with saturation dependence (e.g., Langmuir isotherm). AI-2 levels were proportional to NF loading. DsRed profiles indicate both that: (i) cells responded proportionally to the AI-2 level and (ii) AI-2 concentration increased monotonically over the 26-h owing to sustained Pfs and LuxS enzymatic activity as assembled on chips. Results from Figures 2A to C demonstrate binding of the signal-generating NF to a programmed feature-ladened surface through antigen–antibody interaction. This enabled calibration of both AI-2 productivity and the AI-2 cell response.

A functioning system requires autonomously triggered gene expression of bacterial cells that are immediately proximal or in direct contact with surface features. To design and test this attribute, we engineered bacteria so they would ‘dock' onto surfaces. In Supplementary Figure 2, we expressed Streptococcal protein G (Tanaka et al, 2006) as a surface-displayed fusion with outer membrane protein A (OmpA vector provided by Dr Georgiou; Francisco et al, 1992) in W3110 (ΔlsrFG ΔluxS). This allowed ex vivo assembly of antibody for targeting and docking E. coli to any specified surface. Exactly analogous to NF assembly (Figure 2A), anti-avidin IgG-coated bacteria were loaded onto avidin-coated chips (Figure 2D) and incubated with 40 μM AI-2. The number of bound FITC-labeled bacteria increased linearly with avidin until 50 ng (Figures 2E and F). Correspondingly, the number of AI-2 responding cells also increased linearly, demonstrating that AI-2 sensing bacterial cells were spatially organized on antigen-laden surfaces in proportion to feature density.

QS activation of docked bacteria on PCI-15B via EGFR

In Figure 3A, we identically reformulated these immobilization protocols using SCCHN, PCI-15B (Thomas et al, 2004) (provided by Dr Grandis) that displays EGFR at high levels (Wheeler et al, 2010; Sahu and Grandis, 2011). We used HEK293 (human embryonic kidney cells) for healthy cell controls (low expression of EGFR). Both were seeded in 96-well plates of increasing cell density (also receptor density). E. coli cells were induced with 0.5 mM IPTG for 2 h to express OmpA:protein G followed by coupling of AF488-labeled mouse anti-EGFR IgG (denoted as anti-EGFR). Bacterial cells were then cultivated with PCI-15B and HEK293 cells for EGFR targeting. After 0.5 h, the wells were washed with DPBS to rinse off unbound bacteria and treated with goat anti-mouse coupled NF (Figure 3A). Thus, AI-2 synthesized should be proportional to surface feature density (via linearity between cell number and surface receptor density); also those bacterial cells directly in contact would be exposed to AI-2. After washing with DPBS, an SAH solution was added and bacterial fluorescence was monitored. In Figures 3B and C, fluorescent and bright field images indicate that the anti-EGFR bacteria were bound to the cell surfaces. Moreover, there was a linear increase in bound bacteria with eukaryotic cell number until 10 000/well (R2=0.97). Importantly, after 12 h with SAH, bacterial cells at only the two highest mammalian seeding densities (10 000 and 20 000 cells/well) exhibited DsRed expression indicating the QS switch was ‘on'. Wells with low PCI-15B densities or without NF treatment had minimal DsRed expression, similar to the HEK293 control cell surface. These data demonstrate successful QS-directed switching for surface bound cells and that the resultant threshold limit for initiating gene expression was directly related to EGFR density. Based on previous work (Fernandes et al, 2010) and these data, we estimate 410 bacteria responded to 0.5–2.4 × 109 EGFRs in a 1-mm2 area. This corresponds to ∼0.15–0.75 × 106 EGFRs per cell that falls within the anticipated range (Zimmermann et al, 2006).

AI-2 attracts bacteria

Next, to establish directed bacterial motility we exploited recently discovered AI-2-mediated chemotaxis (Hegde et al, 2011). That is, we created a defined AI-2 gradient as a stimulus for evaluating E. coli motility. A conventional drug-delivery transwell plate apparatus was loaded with 40 μM AI-2 in the upper chamber and W3110 bacteria in the lower chamber; samples from each were withdrawn after 1 and 2 h. In Figure 4A, the calculated concentration gradient is depicted at different regions in the transwell apparatus. While the geometry of the system makes somewhat obscure the exact gradient experienced by each bacterium, the ‘typical' cell as determined by the relative area within the apparatus will be exposed to gradients depicted at points C and D where the gradient is largely dissipated after 20 min. Figures 4B and C demonstrate that one-third of the bacteria originally placed in the lower chamber had swum vertically against gravity into the upper chamber. In the transwell apparatus, we found the bacteria typically needed >1 h to respond and swim the estimated 3.5 mm distance. Subsequent analysis (Supplementary Figures 3–5) showed that at a gradient as small as 0.06 mM/mm was needed to elicit a rapid motility response from sessile E. coli. In a controlled microfluidic device with directionally defined AI-2 gradient, we found the preponderance of bacteria could swim a 0.5-mm distance within 30–40 min.

Functioning programmed system

Results from Figures 1 to 4, f2, f3, f4 demonstrate that time and concentration domains must be known and integrated into a functional system design. In Figure 5, we depict the assembled system comprising motile and sensing/actuating bacteria that (i) detect signal molecules emanating from receptors on tumor cells, (ii) migrate to the tumor cells, and (iii) based on receptor density, initiate gene expression. Recognizing that genome reconstruction in synthetic biology may have metabolic consequences that interfere with programmed function (Bentley et al, 1990; DeLisa et al, 2001; Kwok, 2010), our design comprising only minimally rewired genetic circuits (Tsao et al, 2010). In Figure 5A, we seeded mammalian PCI-15B and HEK293 cells on gelatin-coated glass coverslips, introduced anti-EGFR-NF complexes onto confluent cell layers, and applied SAH (500 μM) into the top compartment of a transwell apparatus. We then turned the gelatin coverslips upside-down allowing direct vertical streamlines from bacteria to mammalian cells. The W3110 (ΔlsrFG ΔluxS) cells were added to the lower wells and after a 9-h incubation (time sufficient for AI-2 synthesis, gradient formation, bacterial migration, and bacterial gene expression) we checked whether the bacteria had successfully migrated upwards to the targeted mammalian surfaces and initiated gene expression. We measured bacterial OD, in vitro AI-2 concentration, bound NF (AF488-labeled anti-EGFR), and also DsRed fluorescence after mammalian cells had been washed off unattached bacteria and NF (Figures 5B and C). The number of bacteria found in the upper chamber was highest for the PCI-15B cells treated with SAH, in accordance with the higher level of AI-2. The levels of AI-2 observed in the upper chamber were ∼5 μM for the NF-treated PCI-15B cells with SAH and ∼1 μM for the NF-treated HEK293 cells. Anti-EGFR-labeled NF was bound to PCI-15B at similar levels irrespective of SAH addition, and ∼1.6-fold more than HEK293. Of note, DsRed fluorescence was highest on PCI-15B cells with SAH (Figures 5C and D). The number of DsRed-expressing bacteria bound to the PCI-15B cells was six times that of those bound to the HEK293 cells. In control experiments with no SAH which had no gradient in AI-2, there was neither a chemotactic response nor altered gene expression (<50 red fluorescing cells; Figures 5B–D). Importantly, the in vitro AI-2 quantified in 15B+SAH sample was 5 μM that was above the determined threshold for the QS switch (Supplementary Figure 1; Fernandes et al, 2010). Note that AI-2 has a dual role in both guiding bacterial chemotaxis and triggering the switching response (DsRed expression; Figure 5C). It was interesting, but unanticipated, that the threshold AI-2 level for lsr gene activation was nearly identical to that needed for cell motility.


Discussion

In summary, the docking of anti-EGFR-NF onto mammalian cell surfaces was specifically controlled by EGFR surface density which, in turn, controlled subsequent AI-2 synthesis, bacteria migration, and the switching response phenotype. The signal generating and cell recruiting design shown here provides a tractable means to ensure site-specific gene initiation, providing a focused and predicted phenotype. While we demonstrate signal transmission and bacterial homing in this system, a reduced system is feasible. For example, bacteria that naturally colonize specific niches could be re-wired to perform switching functions based on prevailing feature densities (e.g., Figures 3B and C) or localized cell number (via self-generated AI-2). As noted earlier, we have intentionally designed this system so that the incorporation of the control functions and output phenotype rely on minimally altered native circuits. This is in contrast to many applications of synthetic biology wherein artificial or metabolically orthogonal controllers (Gardner et al, 2000; Locke et al, 2011), pathways (Ro et al, 2006; Fortin et al, 2007; Atsumi et al, 2008; Dellomonaco et al, 2011), and functions (Elowitz and Leibler, 2000; Fung et al, 2005; Wong et al, 2007; Hsia et al, 2012) are transformed into cells yielding distinctly non-native cell behavior. That is, synthetic biology is replete with examples of novel biological tools (Stephanopoulos, 2002; Zhang et al, 2002; Warner et al, 2010) that endow cells with extraordinary biosynthetic capabilities (Ro et al, 2006; Fortin et al, 2007; Atsumi et al, 2008; Dellomonaco et al, 2011), tolerances (Patnaik et al, 2002; Stephanopoulos, 2002; Yang et al, 2010), and sense and respond phenotypes (Levskaya et al, 2005; Stricker et al, 2008). Often, in such cases, although individual cell productivity remains susceptible to stochastic diversity (Balazsi et al, 2011), cell populations are designed for and also ‘aligned' for optimal production.

In the current work, we envision applications wherein the native QS systems already exist (e.g., GI tract), and Nature's cues feedback on and co-regulate the engineered bacterium (Anderson et al, 2006; Duan and March, 2010; Saeidi et al, 2011). In this way, the bacterium or a small sub-population of like cells, perform functions based on the prevailing conditions. In the system described here, the autoinducer guides both the bacterial motility and gene expression. While we have not engineered motility to respond to different AI-2 gradients, we have engineered cells that actuate gene expression based on different AI-2 concentrations. Perhaps, a single bacterium could be engineered so that chemotaxis and gene expression could be actuated by different concentrations of AI-2. As noted above, we also envision these phenotypes could be completely decoupled, using different signal molecules. We have also noted that motility responds in time domains far more rapidly than gene expression. Hence, the system could be tuned to operate based primarily on time rather than concentration so that distance traveled and gene expression are tuned for a desired function. Finally, while autonomous high-order functioning bacterial cells described here could be added to the growing arsenal of disease fighting bacteria (Forbes, 2006; Mengesha et al, 2007; St Stritzker et al, 2007; Jean et al, 2008; Duan and March, 2010; Patyar et al, 2010; Saeidi et al, 2011; Yu, 2011), we envision many applications wherein bacterial cells are engineered to carry out specified tasks.


Materials and methods
Cell strains and plasmid construction

E. coli K-12 W3110 (ΔlsrFG ΔluxS) was generated using a one-step inactivation method (Datsenko and Wanner, 2000) and were used throughout unless otherwise specified. This strain responds to a significantly lower AI-2 concentration than wild-type W3110 (Supplementary Figure 1). PCI-15B (Thomas et al, 2004) (provided by Dr Jennifer Grandis, University of Pittsburgh) is a cancer cell line that expresses EGFR at high levels. The EGFR displayed on the surface of PCI-15B enable bacterial targeting. HEK293 (human embryonic kidney cell, ATCC # CRL-1573) was used as control cells as they exhibit significantly lower EGFR on their surfaces. Both PCI-15B and HEK293 cells were cultivated in Dulbecco's Modified Eagle's Media (DMEM) containing glucose (4.5 g/l), GlutMAX I (3.97 mM), and 10% fetal bovine serum (FBS, Sigma) at 37°C with 5% CO2. To construct the plasmid pET-DsRed_tac-ompA-proteinG (Supplementary Figure 2A), which encodes DsRed and surface displayed protein G, we performed PCR to amplify the surface display fragment including the outer membrane protein A and signal-peptide (lpp-ompA) sequences from the template vector, pTX101 (provided by Dr George Georgiou, University of Texas, Austin) (Francisco et al, 1992) and a protein G fragment, from pET32-E72G3 (provided by Dr Eiry Kobataki) (Tanaka et al, 2006). Subsequently, a fusion of lpp-ompA and a protein G gene fragment containing a HindIII site was generated again by PCR and then inserted into pET-DsRed with HindIII (NEB) ligation. The resulting plasmid product was then co-transformed along with pCT6 (Tsao et al, 2010) vector into W3110 (ΔlsrFG ΔluxS).

Bacteria response to in vitro AI-2 production

For creating differential antigen surface densities, various concentrations of avidin (Rockland Immunochemicals) were added to pre-treated biotin-coated plates (Pierce). Anti-avidin (FITC) conjugated NFs with 1:2 molar ratio (1/200 × dilution) were applied to guide the NF targeting toward the avidin surface. Bacteria, as described above, were resuspended in Dulbecco's Phosphate Buffer (DPBS; Sigma) containing 1 mM SAH (Sigma) and then incubated in the NF-treated plates. Bacterial responses to AI-2 production were monitored via their fluorescence response using a plate reader (SpectraMax M2; Molecular Devices). In vitro AI-2 levels were measured via a stoichiometric proxy, homocysteine, with the Ellman's assay.

In vitro bacteria targeting and switching/actuating

E. coli cells were induced with 0.5 mM IPTG for 2 h to express protein G followed by AF488-labeled mouse anti-EGFR (Santa Cruz Biotechnology) coupling. Bacterial cells were then applied to a 96-well plate (Greiner Bio-One) cultivated with PCI-15B and HEK293 cells for EGFR targeting. The wells were washed with DPBS to rinse off unbound bacteria and then treated with goat anti-mouse coupled NFs. After washing with DPBS, an SAH solution was added to the wells and bacterial fluorescence response was assessed over 12 h.

Simulation of in vitro AI-2 diffusion profile in the transwell configuration

The time-dependent AI-2 concentration distribution was modeled spatially utilizing COMSOL Multiphysics (COMSOL). Using an axis symmetric COMSOL model with the approximate dimensions of the transwell setup (BD Biosciences) and no flux across any boundaries, simulations were run to ensure that the AI-2 gradient across the transwell membrane persisted throughout the experimental time course. Diffusion was estimated to be 6 × 10−6 (cm2/s) from the Wilke-Chang correlation with water as the solvent.

Chemotaxis due to in vitro synthesized AI-2

In vitro AI-2, SAH, and homocysteine (Sigma) were diluted into equivalent concentrations (40 μM) with DPBS and then added into the top compartment of transwells (3 μm porosity; BD Biosciences) in 6-well plates (Corning). E coli cells resuspended in DPBS (OD600 ∼0.15) were then applied gently into the bottom compartment of the transwells. The plates were then incubated statically at 37oC for 2 h; bacterial dirigible density (OD600) in the top compartment was assessed as a marker of cell motility.

Chemotaxis and QS-initiated gene expression in response to in situ AI-2 produced by locally targeted NFs

PCI-15B and HEK293 cells were seeded onto gelatin-treated glass slides (22 mm round; Fisher Scientific) 1 day before experiments. NF was coupled to anti-EGFR for 30 min incubation (2:1 molar ratio) and then diluted into 1% BSA-DPBS. Afterward, the cells were treated with anti-EGFR-NF for 0.5 h followed by rinsing with DPBS 3 × and placed upside-down into 500 mM SAH (DPBS) containing transwells (3 μm porosity; 6-well plate formats). The glass slides were incubated at 37oC (in 5% CO2) followed by the addition of bacteria (OD600 ∼0.15 in DPBS) into the bottom compartment for a 9-h incubation. AI-2 production, bacterial migration, and genetic responses were examined by Ellman's assay, OD600, and fluorescence microscopy, respectively.


Supplementary Material Supplementary Information

Supplementary Figures S1–6


Review Process File

Notes

The authors declare that they have no conflict of interest.

We would like to thank Dr Jennifer Grandis for generously providing the PCI-15B cell line, Dr George Georgiou for kindly providing the ompA surface display vector, and Dr Eiry Kobatake for providing the Streptococcal protein G vector. This research was funded by the Defense Threat Reduction Agency (DTRA, BO085PO008), the Office of Naval Research (N000141010446), the National Science Foundation (EFRI-0735987) and the R.W. Deutsch Foundation.

Author contributions: H-CW, C-YT, DNQ, YC, KKC, GWR, GFP, JJV, and WEB conceived of the concepts, planned and designed the experiments. H-CW, C-YT, DNQ, MDS, YC, KKC, KJJ, JLT, and AZ performed the experiments and data analyses. H-CW, C-YT, DNQ, KKC, YC, and WEB wrote and edited the manuscript.


References
Anderson JC,, Clarke EJ,, Arkin AP,, Voigt CA, (Year: 2006) Environmentally controlled invasion of cancer cells by engineered bacteria. J Mol Biol355: 619–62716330045
Atsumi S,, Hanai T,, Liao JC, (Year: 2008) Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature451: 86–8918172501
Balazsi G,, van Oudenaarden A,, Collins JJ, (Year: 2011) Cellular decision making and biological noise: from microbes to mammals. Cell144: 910–92521414483
Bentley WE,, Mirjalili N,, Andersen DC,, Davis RH,, Kompala DS, (Year: 1990) Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria. Biotechnol Bioeng35: 668–68118592563
Carnes EC,, Lopez DM,, Donegan NP,, Cheung A,, Gresham H,, Timmins GS,, Brinker CJ, (Year: 2010) Confinement-induced quorum sensing of individual Staphylococcus aureus bacteria. Nat Chem Biol6: 41–4519935660
Datsenko KA,, Wanner BL, (Year: 2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA97: 6640–664510829079
Defoirdt T, (Year: 2011) Can bacteria actively search to join groups?ISME J5: 569–57020882056
DeLisa MP,, Valdes JJ,, Bentley WE, (Year: 2001) Quorum signaling via AI-2 communicates the ‘Metabolic Burden' associated with heterologous protein production in Escherichia coli. Biotechnol Bioeng75: 439–45011668443
Dellomonaco C,, Clomburg JM,, Miller EN,, Gonzalez R, (Year: 2011) Engineered reversal of the beta-oxidation cycle for the synthesis of fuels and chemicals. Nature476: 355–35921832992
Duan F,, March JC, (Year: 2010) Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model. Proc Natl Acad Sci USA107: 11260–1126420534565
Elowitz MB,, Leibler S, (Year: 2000) A synthetic oscillatory network of transcriptional regulators. Nature403: 335–33810659856
Fernandes R,, Roy V,, Wu HC,, Bentley WE, (Year: 2010) Engineered biological nanofactories trigger quorum sensing response in targeted bacteria. Nat Nanotechnol5: 213–21720081846
Fernandes R,, Zuniga M,, Sassine FR,, Karakoy M,, Gracias DH, (Year: 2011) Enabling cargo-carrying bacteria via surface attachment and triggered release. Small7: 588–59221370460
Forbes NS, (Year: 2006) Profile of a bacterial tumor killer. Nat Biotechnol24: 1484–148517160044
Forbes NS, (Year: 2010) Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer10: 785–79420944664
Fortin PD,, Walsh CT,, Magarvey NA, (Year: 2007) A transglutaminase homologue as a condensation catalyst in antibiotic assembly lines. Nature448: 824–82717653193
Francisco JA,, Earhart CF,, Georgiou G, (Year: 1992) Transport and anchoring of beta-lactamase to the external surface of Escherichia coli. Proc Natl Acad Sci USA89: 2713–27171557377
Fung E,, Wong WW,, Suen JK,, Bulter T,, Lee SG,, Liao JC, (Year: 2005) A synthetic gene-metabolic oscillator. Nature435: 118–12215875027
Gardner TS,, Cantor CR,, Collins JJ, (Year: 2000) Construction of a genetic toggle switch in Escherichia coli. Nature403: 339–34210659857
Hegde M,, Englert DL,, Schrock S,, Cohn WB,, Vogt C,, Wood TK,, Manson MD,, Jayaraman A. (Year: 2011) Chemotaxis to the quorum-sensing signal AI-2 requires the Tsr chemoreceptor and the periplasmic LsrB AI-2-binding protein. J Bacteriol193: 768–77321097621
Hooshangi S,, Bentley WE, (Year: 2008) From unicellular properties to multicellular behavior: bacteria quorum sensing circuitry and applications. Curr Opin Biotechnol19: 550–55518977301
Hooshangi S,, Bentley WE, (Year: 2011) LsrR quorum sensing ‘switch' is revealed by a bottom-up approach. PLoS Comput Biol7: e100217221980272
Hsia J,, Holtz WJ,, Huang DC,, Arcak M,, Maharbiz MM, (Year: 2012) A feedback quenched oscillator produces turing patterning with one diffuser. PLoS Comput Biol8: e100233122291582
Kwok R, (Year: 2010) Five hard truths for synthetic biology. Nature463: 288–29020090726
Levskaya A,, Chevalier AA,, Tabor JJ,, Simpson ZB,, Lavery LA,, Levy M,, Davidson EA,, Scouras A,, Ellington AD,, Marcotte EM,, Voigt CA, (Year: 2005) Synthetic biology: engineering Escherichia coli to see light. Nature438: 441–44216306980
Locke JC,, Young JW,, Fontes M,, Hernandez Jimenez MJ,, Elowitz MB, (Year: 2011) Stochastic pulse regulation in bacterial stress response. Science334: 366–36921979936
Mengesha A,, Dubois L,, Chiu RK,, Paesmans K,, Wouters BG,, Lambin P,, Theys J, (Year: 2007) Potential and limitations of bacterial-mediated cancer therapy. Front Biosci12: 3880–389117485344
Miller MB,, Bassler BL, (Year: 2001) Quorum sensing in bacteria. Annu Rev Microbiol55: 165–19911544353
Patnaik R,, Louie S,, Gavrilovic V,, Perry K,, Stemmer WP,, Ryan CM,, del Cardayre S, (Year: 2002) Genome shuffling of Lactobacillus for improved acid tolerance. Nat Biotechnol20: 707–71212089556
Patyar S,, Joshi R,, Byrav DS,, Prakash A,, Medhi B,, Das BK, (Year: 2010) Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci17: 2120331869
Ro DK,, Paradise EM,, Ouellet M,, Fisher KJ,, Newman KL,, Ndungu JM,, Ho KA,, Eachus RA,, Ham TS,, Kirby J,, Chang MC,, Withers ST,, Shiba Y,, Sarpong R,, Keasling JD, (Year: 2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature440: 940–94316612385
Saeidi N,, Wong CK,, Lo TM,, Nguyen HX,, Ling H,, Leong SS,, Poh CL,, Chang MW, (Year: 2011) Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Mol Syst Biol7: 52121847113
Sahu N,, Grandis JR, (Year: 2011) New advances in molecular approaches to head and neck squamous cell carcinoma. Anticancer Drugs22: 656–66421178766
St Jean AT,, Zhang M,, Forbes NS, (Year: 2008) Bacterial therapies: completing the cancer treatment toolbox. Curr Opin Biotechnol19: 511–51718760353
Stephanopoulos G, (Year: 2002) Metabolic engineering by genome shuffling. Nat Biotechnol20: 666–66812089547
Stricker J,, Cookson S,, Bennett MR,, Mather WH,, Tsimring LS,, Hasty J, (Year: 2008) A fast, robust and tunable synthetic gene oscillator. Nature456: 516–51918971928
Stritzker J,, Weibel S,, Hill PJ,, Oelschlaeger TA,, Goebel W,, Szalay AA, (Year: 2007) Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol297: 151–16217448724
Tanaka G,, Funabashi H,, Mie M,, Kobatake E, (Year: 2006) Fabrication of an antibody microwell array with self-adhering antibody binding protein. Anal Biochem350: 298–30316455038
Thomas SM,, Zeng Q,, Epperly MW,, Gooding WE,, Pastan I,, Wang QC,, Greenberger J,, Grandis JR. (Year: 2004) Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38. Clin Cancer Res10: 7079–708715501988
Tsao CY,, Hooshangi S,, Wu HC,, Valdes JJ,, Bentley WE, (Year: 2010) Autonomous induction of recombinant proteins by minimally rewiring native quorum sensing regulon of E. coli. Metab Eng12: 291–29720060924
Warner JR,, Reeder PJ,, Karimpour-Fard A,, Woodruff LB,, Gill RT, (Year: 2010) Rapid profiling of a microbial genome using mixtures of barcoded oligonucleotides. Nat Biotechnol28: 856–86220639866
Waters CM,, Bassler BL, (Year: 2005) Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol21: 319–34616212498
Wheeler DL,, Dunn EF,, Harari PM, (Year: 2010) Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol7: 493–50720551942
Wong WW,, Tsai TY,, Liao JC, (Year: 2007) Single-cell zeroth-order protein degradation enhances the robustness of synthetic oscillator. Mol Syst Biol3: 13017667952
Xie Z,, Wroblewska L,, Prochazka L,, Weiss R,, Benenson Y, (Year: 2011) Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science333: 1307–131121885784
Yang S,, Land ML,, Klingeman DM,, Pelletier DA,, Lu TY,, Martin SL,, Guo HB,, Smith JC,, Brown SD, (Year: 2010) Paradigm for industrial strain improvement identifies sodium acetate tolerance loci in Zymomonas mobilis and Saccharomyces cerevisiae. Proc Natl Acad Sci USA107: 10395–1040020484677
Yu H, (Year: 2011) Bacteria-mediated disease therapy. Appl Microbiol Biotechnol92: 1107–111322033568
Zhang YX,, Perry K,, Vinci VA,, Powell K,, Stemmer WP,, del Cardayre SB, (Year: 2002) Genome shuffling leads to rapid phenotypic improvement in bacteria. Nature415: 644–64611832946
Zimmermann M,, Zouhair A,, Azria D,, Ozsahin M, (Year: 2006) The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. Radiat Oncol1: 1116722544

Article Categories:
  • Article

Keywords: cancer, EGFR, Escherichia coli, quorum sensing, synthetic biology.

Previous Document:  An in vivo control map for the eukaryotic mRNA translation machinery.
Next Document:  Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers.